Oxygen delivery for ambulatory patients. How the Micro-Trach increases mobility.
Transtracheal oxygen delivery with the Micro-Trach is state-of-the-art treatment for patients requiring long-term oxygen therapy. The Micro-Trach diminishes dyspnea because it bypasses the anatomic dead space in the respiratory tract. It eliminates the waste of oxygen that escapes from the nose and mouth when a nasal cannula is used. Therefore, a small oxygen container lasts longer, increasing the patient's mobility. The patient's appetite improves because oxygen is not diverted during deglutition, and the senses of smell and taste are restored. Rehabilitation is enhanced through increased mobility and improved nutrition. Transtracheal instillation of saline solution cleanses the respiratory tract and stimulates coughing, opening occluded air passages. There are fewer lung infections and hospitalizations for infective exacerbations of disease. Prescribed saline solution, mucolytics, and antibiotics can also be instilled through the Micro-Trach to treat cystic fibrosis. This use and others are still being explored.
Heimlich
H J
HJ
Heimlich Institute, Cincinnati, OH.
D000553:Ambulatory Care / Q000379:methods*; D002408:Catheters, Indwelling; D003550:Cystic Fibrosis / Q000628:therapy; D006801:Humans; D008173:Lung Diseases, Obstructive / Q000534:rehabilitation* / Q000628:therapy; D010102:Oxygen Inhalation Therapy / Q000295:instrumentation / Q000379:methods*; D010349:Patient Compliance; D012965:Sodium Chloride / Q000008:administration & dosage; D014139:Tracheostomy / Q000009:adverse effects
D012965:Sodium Chloride